University of Southern California · company speakers →
Dr. Cannon will discuss her laboratory’s application of nuclease technology for both gene disruption and homology-directed editing of the CCR5 locus in hematopoietic stem cells as a novel approach to therapy of HIV infections.
Is this you? Claim this profile →
No public contact links on file.
Speaking history
Topics this speaker covers
Sectors
Sourcing speakers for your event?
Browse the speaker directory →